http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015119841-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff060e7d6685e25501795fa973c65847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2147e072b2badab130df3212389e6b45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48691feff2c858e3085a1d517d966f27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52a21fa1b9de8ffe9ea9307c69978785
publicationDate 2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015119841-A1
titleOfInvention Role of il-23 and pd-1 in autoreactive immune response
abstract The present invention provides methods of screening subjects for the presence of IL-23R+/PD-1 + gamma-delta T-cells as a marker of autoreactive immune disorders, use of such identification in directing treatment, and related methods of treatment. The invention also provides use of such IL-23R+/PD-1 + gamma-delta T-cells in screening for agents useful in treating autoreactive immune disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018093841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021308220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019090329-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10766958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023064278-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11780911-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11548941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10428145-B2
priorityDate 2014-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012213781-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8193321-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5223426-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013156790-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57472993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416392

Total number of triples: 51.